May 15, 2026
General Accident Insurance Co. Ja. Ltd. (GENAC)
Unaudited financials for the three months ended March 31, 2026:
General Accident Insurance Co. Ja. Ltd. (GENAC) for the three months ended March 31, 2026 reported an 18% increase in insurance revenue totaling $3.59 billion compared to $3.04 billion in the corresponding period last year.
Insurance Service Expenses amounted to $2.02 billion (2025: $1.75 billion), this represents an increase of 15% year over year. Additionally, net expenses from reinsurance contracts held increased by 9% to $1.30 billion compared to $1.19 billion for the three months ended March 31, 2025.
Insurance service result increased by 190% to close at $273.73 million (2025: $94.44 million), while Net Investment Income increased by 24% from $137.21 million in 2025 to $170.32 million in the period under review. As a result, net insurance and investment result for the three months ended March 31, 2026, amounted to $444.05 million, a 92% increase relative to $231.65 million reported in 2025.
Other Operating Income for the three months ended March 31, 2026, amounted to $29.97 million, a 62% decrease relative to $78.93 million reported in 2025. Other Operating Expenses totaled $157.77 million, a 14% increase from the corresponding period last year (2025: $138.46 million).
Profit before taxation for the three months ended March 31, 2026, amounted to $316.25 million, an 84% increase relative to $172.12 million reported in 2025.
The tax charge incurred for the three months ended March 31, 2026 had a 202% increase to reach $66.34 million (2025: $21.94 million). As a result, Net Profit for the three months amounted to $249.91 million, a 66% increase from the $150.18 million reported in 2025. Net profit attributable to shareholders for the three months ended March 31, 2026 had a 61% increase to reach $231.26 million (2025: $143.91 million).
Unrealized losses on FVOCI investments for the three months ended March 31, 2026 amounted to $22.86 million (2025: gains of $20.17 million). Foreign currency translation adjustments amounted to $2.07 million (2025: loss of $37.68 million).
Total Comprehensive Income for the period totaled $229.12 million, relative to the $132.67 million reported in the same period last year.
Consequently, Earnings Per Share for the three months amounted to $0.22 (2025: EPS: $0.14). The twelve-month trailing EPS was $0.51, and the number of shares used in these calculations was 1,031,250,000.
Notably, GENAC’s stock price closed the trading period on May 14, 2026, at a price of $6.49 with a corresponding P/E ratio of 12.64x.
Balance Sheet Highlights
The company’s assets totaled $21.48 billion (2025: $14.35 billion). The movement in total assets was mainly influenced by a $6.41 billion increase in ‘Reinsurance contract assets’ amounting to $10.12 billion (2025: $3.71 billion) and a $957.66 million increase in ‘Investment securities’ amounting to $4.52 billion (2025: $3.57 billion).
Shareholder’s equity was $4.42 billion (2025: $3.96 billion), representing a book value per share of $4.28 (2025: $3.84).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
